ES2061319T3 - Utilizacion de derivados 4-(3-trifluorometifenil)-1,2,3,6-tetrahidropiridinicos como captadores de radicales libres. - Google Patents

Utilizacion de derivados 4-(3-trifluorometifenil)-1,2,3,6-tetrahidropiridinicos como captadores de radicales libres.

Info

Publication number
ES2061319T3
ES2061319T3 ES92400289T ES92400289T ES2061319T3 ES 2061319 T3 ES2061319 T3 ES 2061319T3 ES 92400289 T ES92400289 T ES 92400289T ES 92400289 T ES92400289 T ES 92400289T ES 2061319 T3 ES2061319 T3 ES 2061319T3
Authority
ES
Spain
Prior art keywords
free radicals
compounds
trifluorometifenil
tetrahidropiridinicos
collectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92400289T
Other languages
English (en)
Inventor
Michel Heaulme
Umberto Guzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elf Sanofi SA
Original Assignee
Elf Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi SA filed Critical Elf Sanofi SA
Application granted granted Critical
Publication of ES2061319T3 publication Critical patent/ES2061319T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE COMPUESTOS DE FORMULA (I): EN LA QUE R Y R SUB 1, CADA UNO INDEPENDIENTEMENTE, REPRESENTAN UN ATOMO DE HIDROGENO O UN GRUPO METILO, Y DE SUS SALES DE ADICION DE ACIDOS FARMACEUTICAMENTE ACEPTABLES COMO CAPTADORES DE RADICALES LIBRES. LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS SIRVEN DE MEDICAMENTOS EN TODOS LOS PROCESOS PATOLOGICOS QUE OCASIONAN DAÑOS CELULARES QUE ESTAN RELACIONADOS CON LA FORMACION DE RADICALES LIBRES. LA INVENCION SE REFIERE TAMBIEN A LOS COMPUESTOS DE FORMULA (I), EN LA QUE AL MENOS UNO DE LOS RADICALES R Y R SUB 1 ES UN GRUPO METILO, QUE SON PRODUCTOS NUEVOS, ASI COMO AL PROCESO PARA SU PREPARACION Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES92400289T 1991-02-05 1992-02-05 Utilizacion de derivados 4-(3-trifluorometifenil)-1,2,3,6-tetrahidropiridinicos como captadores de radicales libres. Expired - Lifetime ES2061319T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101283A FR2672213B1 (fr) 1991-02-05 1991-02-05 Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.

Publications (1)

Publication Number Publication Date
ES2061319T3 true ES2061319T3 (es) 1994-12-01

Family

ID=9409370

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92400289T Expired - Lifetime ES2061319T3 (es) 1991-02-05 1992-02-05 Utilizacion de derivados 4-(3-trifluorometifenil)-1,2,3,6-tetrahidropiridinicos como captadores de radicales libres.

Country Status (13)

Country Link
US (1) US5292745A (es)
EP (1) EP0498718B1 (es)
JP (1) JP3471820B2 (es)
AT (1) ATE109467T1 (es)
AU (1) AU649099B2 (es)
CA (1) CA2060616C (es)
DE (1) DE69200284T2 (es)
DK (1) DK0498718T3 (es)
ES (1) ES2061319T3 (es)
FR (1) FR2672213B1 (es)
HU (2) HU212945B (es)
IE (1) IE66593B1 (es)
MX (1) MX9200485A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.
ES2159362T3 (es) * 1995-10-26 2001-10-01 Sanofi Synthelabo Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
FR2740343B1 (fr) * 1995-10-26 1999-01-22 Sanofi Sa Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique
FR2763847B1 (fr) 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
ATE419843T1 (de) * 1998-12-01 2009-01-15 Alexandre T Rotta Methode zur in vitro reduzierung von durch freie radikale induzierte schäden
CA2455896A1 (en) * 2001-08-29 2003-03-13 Alcon, Inc. Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
EA200700118A1 (ru) * 2004-06-24 2007-08-31 Инсайт Корпорейшн Амидосоединения и их применение в качестве лекарственных средств
CA2584502A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation 2-methylpropanamides and their use as pharmaceuticals
US20060009491A1 (en) * 2004-06-24 2006-01-12 Incyte Corporation Amido compounds and their use as pharmaceuticals
EP1758580A4 (en) 2004-06-24 2008-01-16 Incyte Corp N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT
US20060122197A1 (en) * 2004-08-10 2006-06-08 Wenqing Yao Amido compounds and their use as pharmaceuticals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2501682A1 (fr) * 1981-03-11 1982-09-17 Sanofi Sa Trifluoromethylphenylpyridines a activite anorexigene, un procede de preparation et compositions pharmaceutiques en contenant
US4691019A (en) * 1981-03-11 1987-09-01 Sanofi Anorectic agent; 4-(3-trifluoromethylphenyl)-1-(2-cyanoethyl)-1,2,3,6-tetrahydropyridine
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
GB2226269B (en) * 1988-12-22 1992-11-25 Zdzislaw Bieganski Cable stripper
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
MX9200485A (es) 1992-11-01
EP0498718B1 (fr) 1994-08-03
EP0498718A1 (fr) 1992-08-12
DK0498718T3 (da) 1994-12-05
JPH04312528A (ja) 1992-11-04
HUT62563A (en) 1993-05-28
HU212945B (en) 1996-12-30
DE69200284D1 (de) 1994-09-08
AU1065592A (en) 1992-08-13
FR2672213B1 (fr) 1995-03-10
AU649099B2 (en) 1994-05-12
CA2060616C (en) 2004-04-06
US5292745A (en) 1994-03-08
DE69200284T2 (de) 1995-03-02
IE66593B1 (en) 1996-01-24
JP3471820B2 (ja) 2003-12-02
ATE109467T1 (de) 1994-08-15
FR2672213A1 (fr) 1992-08-07
CA2060616A1 (en) 1992-08-06
IE920354A1 (en) 1992-08-12
HU211457A9 (en) 1995-11-28
HU9200335D0 (en) 1992-04-28

Similar Documents

Publication Publication Date Title
DE69109631T2 (de) 2-Substituierte Adenosinderivate und pharmazeutische Zusammensetzungen zur Verwendung gegen Infektionskrankheiten.
ES2061319T3 (es) Utilizacion de derivados 4-(3-trifluorometifenil)-1,2,3,6-tetrahidropiridinicos como captadores de radicales libres.
ES8403858A1 (es) Procedimiento para la preparacion de dipeptidos carboxialquilicos.
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
HUT36113A (en) Process for preparing dihydro-pyridibes with anti-ischaemic activity and blood pressure decreasing effect and pharmaceutical compositions containing such compounds
ES8504738A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
SE8406302D0 (sv) New aminoguanidine derivatives and a process for the preparation thereof
ATE24503T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
DE69909782D1 (de) Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ATE66476T1 (de) Thianaphthen-derivate, ihre herstellung und verwendung.
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
MA20369A1 (fr) Compositions a base de derives de la piperidine ,nouveaux derives de la piperidine et leurs procedes de preparation
NO162017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater.
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ATE96434T1 (de) 2-(heteroalkyl)-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE28632T1 (de) Piperidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE78032T1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK0619817T3 (da) Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
TH20908B (th) อนุพันธ์คาร์โบไฮเดรต
TH31635A (th) อนุพันธ์คาร์โบไฮเดรต
TH2445A (th) ไพริมิดีนที่ถูกแทนที่
TH8799EX (th) การใช้อนุพันธ์ของอิมิแดโซพิแรโซลเป็นสารแก้ปวดและต่อต้านการอักเสบ
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 498718

Country of ref document: ES

FA2A Application withdrawn

Effective date: 19941215